Role of monocytes in the pathogenesis of antiphospholipid syndrome and potential therapeutic targets (Review)

Barbhaiya M, Zuily S, Naden R, Hendry A, Manneville F, Amigo MC, Amoura Z, Andrade D, Andreoli L, Artim-Esen B, et al: 2023 ACR/EULAR antiphospholipid syndrome classification criteria. Ann Rheum Dis. 82:1258–1270. 2023. View Article : Google Scholar : PubMed/NCBI

Radic M and Pattanaik D: Cellular and molecular mechanisms of anti-phospholipid syndrome. Front Immunol. 9:9692018. View Article : Google Scholar : PubMed/NCBI

Knight JS and Kanthi Y: Mechanisms of immunothrombosis and vasculopathy in antiphospholipid syndrome. Semin Immunopathol. 44:347–362. 2022. View Article : Google Scholar : PubMed/NCBI

Hernández-Molina G, González-Pérez I, Pacheco-Molina C and Cabral AR: Quality of life in patients with antiphospholipid syndrome is related to disease burden and anticoagulant therapy. Int J Rheum Dis. 20:755–759. 2017. View Article : Google Scholar : PubMed/NCBI

Chighizola CB, Crisafulli F, Hoxha A, Carubbi F, Bellan M, Monti S, Costa L, Baldi C, Radin M, Praino E, et al: Psychosocial burden in young patients with primary anti-phospholipid syndrome: An Italian nationwide survey (The AQUEOUS study). Clin Exp Rheumatol. 39:938–946. 2021. View Article : Google Scholar : PubMed/NCBI

Velásquez M, Peláez LF, Rojas M, Narváez-Sánchez R, Velásquez JA, Escudero C, San Martín S and Cadavid ÁP: Differences in endothelial activation and dysfunction induced by antiphospholipid antibodies among groups of patients with thrombotic, refractory, and non-refractory antiphospholipid syndrome. Front Physiol. 12:7647022021. View Article : Google Scholar : PubMed/NCBI

Redecha P, Tilley R, Tencati M, Salmon JE, Kirchhofer D, Mackman N and Girardi G: Tissue factor: A link between C5a and neutrophil activation in antiphospholipid antibody induced fetal injury. Blood. 110:2423–2431. 2007. View Article : Google Scholar : PubMed/NCBI

Salmon JE and Girardi G: Antiphospholipid antibodies and pregnancy loss: A disorder of inflammation. J Reprod Immunol. 77:51–56. 2008. View Article : Google Scholar : PubMed/NCBI

Proulle V, Furie RA, Merrill-Skoloff G, Furie BC and Furie B: Platelets are required for enhanced activation of the endothelium and fibrinogen in a mouse thrombosis model of APS. Blood. 124:611–622. 2014. View Article : Google Scholar : PubMed/NCBI

Wahl D, Membre A, Perret-Guillaume C, Regnault V and Lecompte T: Mechanisms of antiphospholipid-induced thrombosis: Effects on the protein C system. Curr Rheumatol Rep. 11:77–81. 2009. View Article : Google Scholar : PubMed/NCBI

Bu C, Gao L, Xie W, Zhang J, He Y, Cai G and McCrae KR: beta2-glycoprotein i is a cofactor for tissue plasminogen activator-mediated plasminogen activation. Arthritis Rheum. 60:559–568. 2009. View Article : Google Scholar : PubMed/NCBI

Yalavarthi S, Gould TJ, Rao AN, Mazza LF, Morris AE, Núñez-Álvarez C, Hernández-Ramírez D, Bockenstedt PL, Liaw PC, Cabral AR and Knight JS: Release of neutrophil extracellular traps by neutrophils stimulated with antiphospholipid antibodies: A newly identified mechanism of thrombosis in the antiphospholipid syndrome. Arthritis Rheumatol. 67:2990–3003. 2015. View Article : Google Scholar : PubMed/NCBI

Kuwana M: Beta2-glycoprotein I: Antiphospholipid syndrome and T-cell reactivity. Thromb Res. 114:347–355. 2004. View Article : Google Scholar : PubMed/NCBI

Chaturvedi S, Alluri R and McCrae KR: Extracellular vesicles in the antiphospholipid syndrome. Semin Thromb Hemost. 44:493–504. 2018. View Article : Google Scholar : PubMed/NCBI

Rand JH, Wu XX, Guller S, Gil J, Guha A, Scher J and Lockwood CJ: Reduction of annexin-V (placental anticoagulant protein-I) on placental villi of women with antiphospholipid antibodies and recurrent spontaneous abortion. Am J Obstet Gynecol. 171:1566–1572. 1994. View Article : Google Scholar : PubMed/NCBI

Doğan Z, Bektaşoğlu G, Dümür Ş, Uzun H, Erden İ and Yurtdaş M: Evaluation of the relationship between monocyte to high-density lipoprotein cholesterol ratio and thrombus burden in patients with deep vein thrombosis. Rev Assoc Med Bras (1992). 69:e202212112023. View Article : Google Scholar : PubMed/NCBI

Chen P, Zhou L, Chen J, Lu Y, Cao C, Lv S, Wei Z, Wang L, Chen J, Hu X, et al: The immune atlas of human deciduas with unexplained recurrent pregnancy loss. Front Immunol. 12:6890192021. View Article : Google Scholar : PubMed/NCBI

Oku K, Amengual O and Atsumi T: Pathophysiology of thrombosis and pregnancy morbidity in the antiphospholipid syndrome. Eur J Clin Invest. 42:1126–1135. 2012. View Article : Google Scholar : PubMed/NCBI

Xourgia E and Tektonidou MG: An update on antiphospholipid syndrome. Curr Rheumatol Rep. 23:842022. View Article : Google Scholar : PubMed/NCBI

Dabit JY, Valenzuela-Almada MO, Vallejo-Ramos S and Duarte-García A: Epidemiology of antiphospholipid syndrome in the general population. Curr Rheumatol Rep. 23:852022. View Article : Google Scholar : PubMed/NCBI

Hwang JJ, Shin SH, Kim YJ, Oh YM, Lee SD, Kim YH, Choi CW and Lee JS: Epidemiology of antiphospholipid syndrome in Korea: A nationwide population-based study. J Korean Med Sci. 35:e352020. View Article : Google Scholar : PubMed/NCBI

Radin M, Sciascia S, Bazzan M, Bertero T, Carignola R, Montabone E, Montaruli B, Vaccarino A, Cecchi I, Rubini E, et al: Antiphospholipid syndrome is still a rare disease-estimated prevalence in the piedmont and aosta valley regions of northwest Italy: Comment on the article by Duarte-García et al. Arthritis Rheumatol. 72:1774–1776. 2020. View Article : Google Scholar : PubMed/NCBI

Duarte-García A, Pham MM, Crowson CS, Amin S, Moder KG, Pruthi RK, Warrington KJ and Matteson EL: The epidemiology of antiphospholipid syndrome: A population-based study. Arthritis Rheumatol. 71:1545–1552. 2019. View Article : Google Scholar : PubMed/NCBI

Petri M: Antiphospholipid syndrome. Transl Res. 225:70–81. 2020. View Article : Google Scholar : PubMed/NCBI

Cervera R, Serrano R, Pons-Estel GJ, Ceberio-Hualde L, Shoenfeld Y, de Ramón E, Buonaiuto V, Jacobsen S, Zeher MM, Tarr T, et al: Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: A multicentre prospective study of 1000 patients. Ann Rheum Dis. 74:1011–1018. 2015. View Article : Google Scholar : PubMed/NCBI

D'Ippolito S, Barbaro G, Paciullo C, Tersigni C, Scambia G and Di Simone N: Antiphospholipid syndrome in pregnancy: New and old pathogenetic mechanisms. Int J Mol Sci. 24:31952023. View Article : Google Scholar : PubMed/NCBI

Turrent-Carriles A, Herrera-Félix JP and Amigo MC: Renal involvement in antiphospholipid syndrome. Front Immunol. 9:10082018. View Article : Google Scholar : PubMed/NCBI

Abreu MM, Danowski A, Wahl DG, Amigo MC, Tektonidou M, Pacheco MS, Fleming N, Domingues V, Sciascia S, Lyra JO, et al: The relevance of ‘non-criteria’ clinical manifestations of antiphospholipid syndrome: 14th international congress on antiphospholipid antibodies technical task force report on antiphospholipid syndrome clinical features. Autoimmun Rev. 14:401–414. 2015. View Article : Google Scholar : PubMed/NCBI

Pignatelli P, Ettorre E, Menichelli D, Pani A, Violi F and Pastori D: Seronegative antiphospholipid syndrome: Refining the value of ‘non-criteria’ antibodies for diagnosis and clinical management. Haematologica. 105:562–572. 2020. View Article : Google Scholar : PubMed/NCBI

Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, Derksen RH, DE Groot PG, Koike T, Meroni PL, et al: International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost. 4:295–306. 2006. View Article : Google Scholar : PubMed/NCBI

Asherson RA, Cervera R, de Groot PG, Erkan D, Boffa MC, Piette JC, Khamashta MA and Shoenfeld Y; Catastrophic Antiphospholipid Syndrome Registry Project Group, : Catastrophic antiphospholipid syndrome: International consensus statement on classification criteria and treatment guidelines. Lupus. 12:530–534. 2003. View Article : Google Scholar : PubMed/NCBI

Auffray C, Sieweke MH and Geissmann F: Blood monocytes: Development, heterogeneity, and relationship with dendritic cells. Annu Rev Immunol. 27:669–692. 2009. View Article : Google Scholar : PubMed/NCBI

Ziegler-Heitbrock L: Blood monocytes and their subsets: Established features and open questions. Front Immunol. 6:4232015. View Article : Google Scholar : PubMed/NCBI

Kzhyshkowska J, Gudima A, Moganti K, Gratchev A and Orekhov A: Perspectives for monocyte/macrophage-based diagnostics of chronic inflammation. Transfus Med Hemother. 43:66–77. 2016. View Article : Google Scholar : PubMed/NCBI

Geissmann F, Manz MG, Jung S, Sieweke MH, Merad M and Ley K: Development of monocytes, macrophages, and dendritic cells. Science. 327:656–561. 2010. View Article : Google Scholar : PubMed/NCBI

Dash SP, Gupta S and Sarangi PP: Monocytes and macrophages: Origin, homing, differentiation, and functionality during inflammation. Heliyon. 10:e296862024. View Article : Google Scholar : PubMed/NCBI

Cormican S and Griffin MD: Human monocyte subset distinctions and function: Insights from gene expression analysis. Front Immunol. 11:10702020. View Article : Google Scholar : PubMed/NCBI

Ziegler-Heitbrock L, Ancuta P, Crowe S, Dalod M, Grau V, Hart DN, Leenen PJ, Liu YJ, MacPherson G, Randolph GJ, et al: Nomenclature of monocytes and dendritic cells in blood. Blood. 116:e74–e80. 2010. View Article : Google Scholar : PubMed/NCBI

Wong KL, Yeap WH, Tai JJ, Ong SM, Dang TM and Wong SC: The three human monocyte subsets: Implications for health and disease. Immunol Res. 53:41–57. 2012. View Article : Google Scholar : PubMed/NCBI

Medrano-Bosch M, Simón-Codina B, Jiménez W, Edelman ER and Melgar-Lesmes P: Monocyte-endothelial cell interactions in vascular and tissue remodeling. Front Immunol. 14:11960332023. View Article : Google Scholar : PubMed/NCBI

Wong KL, Tai JJ, Wong WC, Han H, Sem X, Yeap WH, Kourilsky P and Wong SC: Gene expression profiling reveals the defining features of the classical, intermediate, and nonclassical human monocyte subsets. Blood. 118:e16–e31. 2011. View Article : Google Scholar : PubMed/NCBI

Cros J, Cagnard N, Woollard K, Patey N, Zhang SY, Senechal B, Puel A, Biswas SK, Moshous D, Picard C, et al: Human CD14dim monocytes patrol and sense nucleic acids and viruses via TLR7 and TLR8 receptors. Immunity. 33:375–386. 2010. View Article : Google Scholar : PubMed/NCBI

Štok U, Štucin N, Blokar E, Ambrožič A, Sodin-Šemrl S, Čučnik S and Žigon P: Antiphospholipid antibody syndrome-associated increased surface expression of VLA4 integrin on human monocytes. Biomedicines. 10:23412022. View Article : Google Scholar : PubMed/NCBI

Mandel J, Casari M, Stepanyan M, Martyanov A and Deppermann C: Beyond hemostasis: Platelet innate immune interactions and thromboinflammation. Int J Mol Sci. 23:38682022. View Article : Google Scholar : PubMed/NCBI

Hui H, Fuller KA, Erber WN and Linden MD: Imaging flow cytometry in the assessment of leukocyte-platelet aggregates. Methods. 112:46–54. 2017. View Article : Google Scholar : PubMed/NCBI

Gawaz MP, Loftus JC, Bajt ML, Frojmovic MM, Plow EF and Ginsberg MH: Ligand bridging mediates integrin alpha IIb beta 3 (platelet GPIIB-IIIA) dependent homotypic and heterotypic cell-cell interactions. J Clin Invest. 88:1128–1134. 1991. View Article : Google Scholar : PubMed/NCBI

Silverstein RL, Asch AS and Nachman RL: Glycoprotein IV mediates thrombospondin-dependent platelet-monocyte and platelet-U937 cell adhesion. J Clin Invest. 84:546–552. 1989. View Article : Google Scholar : PubMed/NCBI

Han Z, Liu Q, Li H, Zhang M, You L, Lin Y, Wang K, Gou Q, Wang Z, Zhou S, et al: The role of monocytes in thrombotic diseases: A review. Front Cardiovasc Med. 10:11138272023. View Article : Google Scholar : PubMed/NCBI

von Hundelshausen P, Weber KS, Huo Y, Proudfoot AE, Nelson PJ, Ley K and Weber C: RANTES deposition by platelets triggers monocyte arrest on inflamed and atherosclerotic endothelium. Circulation. 103:1772–1777. 2001. View Article : Google Scholar : PubMed/NCBI

Moore KL, Stults NL, Diaz S, Smith DF, Cummings RD, Varki A and McEver RP: Identification of a specific glycoprotein ligand for P-selectin (CD62) on myeloid cells. J Cell Biol. 118:445–456. 1992. View Article : Google Scholar : PubMed/NCBI

Ivanov II, Apta BHR, Bonna AM and Harper MT: Platelet P-selectin triggers rapid surface exposure of tissue factor in monocytes. Sci Rep. 9:133972019. View Article : Google Scholar : PubMed/NCBI

Purdy M, Obi A, Myers D and Wakefield T: P- and E-selectin in venous thrombosis and non-venous pathologies. J Thromb Haemost. 20:1056–1066. 2022. View Article : Google Scholar : PubMed/NCBI

Maugeri N, Brambilla M, Camera M, Carbone A, Tremoli E, Donati MB, de Gaetano G and Cerletti C: Human polymorphonuclear leukocytes produce and express functional tissue factor upon stimulation. J Thromb Haemost. 4:1323–1330. 2006. View Article : Google Scholar : PubMed/NCBI

Hottz ED, Martins-Gonçalves R, Palhinha L, Azevedo-Quintanilha IG, de Campos MM, Sacramento CQ, Temerozo JR, Soares VC, Dias SSG, Teixeira L, et al: Platelet-monocyte interaction amplifies thromboinflammation through tissue factor signaling in COVID-19. Blood Adv. 6:5085–5099. 2022. View Article : Google Scholar : PubMed/NCBI

Melgert BN, Spaans F, Borghuis T, Klok PA, Groen B, Bolt A, de Vos P, van Pampus MG, Wong TY, van Goor H, et al: Pregnancy and preeclampsia affect monocyte subsets in humans and rats. PLoS One. 7:e452292012. View Article : Google Scholar : PubMed/NCBI

Torchinsky A, Shepshelovich J, Orenstein H, Zaslavsky Z, Savion S, Carp H, Fain A and Toder V: TNF-alpha protects embryos exposed to developmental toxicants. Am J Reprod Immunol. 49:159–168. 2003. View Article : Google Scholar : PubMed/NCBI

Piccinni MP, Raghupathy R, Saito S and Szekeres-Bartho J: Cytokines, hormones and cellular regulatory mechanisms favoring successful reproduction. Front Immunol. 12:7178082021. View Article : Google Scholar : PubMed/NCBI

Casazza RL, Lazear HM and Miner JJ: Protective and pathogenic effects of interferon signaling during pregnancy. Viral Immunol. 33:3–11. 2020. View Article : Google Scholar : PubMed/NCBI

Yang X, Tian Y, Zheng L, Luu T and Kwak-Kim J: The update immune-regulatory role of pro- and anti-inflammatory cytokines in recurrent pregnancy losses. Int J Mol Sci. 24:1322022. View Article : Google Scholar : PubMed/NCBI

Michimata T, Tsuda H, Sakai M, Fujimura M, Nagata K, Nakamura M and Saito S: Accumulation of CRTH2-positive T-helper 2 and T-cytotoxic 2 cells at implantation sites of human decidua in a prostaglandin D(2)-mediated manner. Mol Hum Reprod. 8:181–187. 2002. View Article : Google Scholar : PubMed/NCBI

Mitchell RE, Hassan M, Burton BR, Britton G, Hill EV, Verhagen J and Wraith DC: IL-4 enhances IL-10 production in Th1 cells: implications for Th1 and Th2 regulation. Sci Rep. 7:113152017. View Article : Google Scholar : PubMed/NCBI

Shi JW, Yang HL, Fan DX, Yang SL, Qiu XM, Wang Y, Lai ZZ, Ha SY, Ruan LY, Shen HH, et al: The role of CXC chemokine ligand 16 in physiological and pathological pregnancies. Am J Reprod Immunol. 83:e132232020. View Article : Google Scholar : PubMed/NCBI

Shao Q, Liu X, Huang Y, Chen X and Wang H: Human decidual stromal cells in early pregnancy induce functional re-programming of monocyte-derived dendritic cells via crosstalk between G-CSF and IL-1β. Front Immunol. 11:5742702020. View Article : Google Scholar : PubMed/NCBI

Álvarez D, Morales-Prieto DM and Cadavid ÁP: Interaction between endothelial cell-derived extracellular vesicles and monocytes: A potential link between vascular thrombosis and pregnancy-related morbidity in antiphospholipid syndrome. Autoimmun Rev. 22:1032742023. View Article : Google Scholar : PubMed/NCBI

Erez O, Romero R, Jung E, Chaemsaithong P, Bosco M, Suksai M, Gallo DM and Gotsch F: Preeclampsia and eclampsia: The conceptual evolution of a syndrome. Am J Obstet Gynecol. 226((2S)): S786–S803. 2022. View Article : Google Scholar : PubMed/NCBI

Xie H, Zhou H, Wang H, Chen D, Xia L, Wang T and Yan J: Anti-β(2)GPI/β(2)GPI induced TF and TNF-α expression in monocytes involving both TLR4/MyD88 and TLR4/TRIF signaling pathways. Mol Immunol. 53:246–254. 2013. View Article : Google Scholar : PubMed/NCBI

Colasanti T, Alessandri C, Capozzi A, Sorice M, Delunardo F, Longo A, Pierdominici M, Conti F, Truglia S, Siracusano A, et al: Autoantibodies specific to a peptide of β2-glycoprotein I cross-react with TLR4, inducing a proinflammatory phenotype in endothelial cells and monocytes. Blood. 120:3360–3370. 2012. View Article : Google Scholar : PubMed/NCBI

Raschi E, Chighizola CB, Grossi C, Ronda N, Gatti R, Meroni PL and Borghi MO: β2-glycoprotein I, lipopolysaccharide and endothelial TLR4: Three players in the two hit theory for anti-phospholipid-mediated thrombosis. J Autoimmun. 55:42–50. 2014. View Article : Google Scholar : PubMed/NCBI

Brandt KJ, Fickentscher C, Boehlen F, Kruithof EKO and de Moerloose P: NF-κB is activated from endosomal compartments in antiphospholipid antibodies-treated human monocytes. J Thromb Haemost. 12:779–791. 2014. View Article : Google Scholar : PubMed/NCBI

Müller-Calleja N, Köhler A, Siebald B, Canisius A, Orning C, Radsak M, Stein P, Mönnikes R and Lackner KJ: Cofactor-independent antiphospholipid antibodies activate the NLRP3-inflammasome via endosomal NADPH-oxidase: Implications for the antiphospholipid syndrome. Thromb Haemost. 113:1071–1083. 2015. View Article : Google Scholar : PubMed/NCBI

Hurst J, Prinz N, Lorenz M, Bauer S, Chapman J, Lackner KJ and von Landenberg P: TLR7 and TLR8 ligands and antiphospholipid antibodies show synergistic effects on the induction of IL-1beta and caspase-1 in monocytes and dendritic cells. Immunobiology. 214:683–691. 2009. View Article : Google Scholar : PubMed/NCBI

Tektonidou MG: Cardiovascular disease risk in antiphospholipid syndrome: Thrombo-inflammation and atherothrombosis. J Autoimmun. 128:1028132022. View Article : Google Scholar : PubMed/NCBI

Benagiano M, Borghi MO, Romagnoli J, Mahler M, Bella CD, Grassi A, Capitani N, Emmi G, Troilo A, Silvestri E, et al: Interleukin-17/Interleukin-21 and Interferon-γ producing T cells specific for β2 Glycoprotein I in atherosclerosis inflammation of systemic lupus erythematosus patients with antiphospholipid syndrome. Haematologica. 104:2519–2527. 2019. View Article : Google Scholar : PubMed/NCBI

Xia L, Zhou H, Wang T, Xie Y, Wang T, Wang X and Yan J: Activation of mTOR is involved in anti-β₂GPI/β₂GPI-induced expression of tissue factor and IL-8 in monocytes. Thromb Res. 157:103–110. 2017. View Article : Google Scholar : PubMed/NCBI

Niyonzima N, Rahman J, Kunz N, West EE, Freiwald T, Desai JV, Merle NS, Gidon A, Sporsheim B, Lionakis MS, et al: Mitochondrial C5aR1 activity in macrophages controls IL-1β production underlying sterile inflammation. Sci Immunol. 6:eabf24892021. View Article : Google Scholar : PubMed/NCBI

Khoy K, Mariotte D, Defer G, Petit G, Toutirais O and Le Mauff B: Natalizumab in multiple sclerosis treatment: from biological effects to immune monitoring. Front Immunol. 11:5498422020. View Article : Google Scholar : PubMed/NCBI

Cheng S, Wang H and Zhou H: The role of TLR4 on B cell activation and anti-β₂GPI antibody production in the antiphospholipid syndrome. J Immunol Res. 2016:17197202016. View Article : Google Scholar : PubMed/NCBI

Chaturvedi S, Brodsky RA and McCrae KR: Complement in the pathophysiology of the antiphospholipid syndrome. Front Immunol. 10:4492019. View Article : Google Scholar : PubMed/NCBI

Kiss MG, Papac-Miličević N, Porsch F, Tsiantoulas D, Hendrikx T, Takaoka M, Dinh HQ, Narzt MS, Göderle L, Ozsvár-Kozma M, et al: Cell-autonomous regulation of complement C3 by factor H limits macrophage efferocytosis and exacerbates atherosclerosis. Immunity. 56:1809–1824.e10. 2023. View Article : Google Scholar : PubMed/NCBI

Girardi G, Yarilin D, Thurman JM, Holers VM and Salmon JE: Complement activation induces dysregulation of angiogenic factors and causes fetal rejection and growth restriction. J Exp Med. 203:2165–2175. 2006. View Article : Google Scholar : PubMed/NCBI

Lin Z, Shi JL, Chen M, Zheng ZM, Li MQ and Shao J: CCL2: An important cytokine in normal and pathological pregnancies: A review. Front Immunol. 13:10534572023. View Article : Google Scholar : PubMed/NCBI

Shields CA, McCalmon M, Ibrahim T, White DL, Williams JM, LaMarca B and Cornelius DC: Placental ischemia-stimulated T-helper 17 cells induce preeclampsia-associated cytolytic natural killer cells during pregnancy. Am J Physiol Regul Integr Comp Physiol. 315:R336–R343. 2018. View Article : Google Scholar : PubMed/NCBI

Wang W, Sung N, Gilman-Sachs A and Kwak-Kim J: T helper (Th) cell profiles in pregnancy and recurrent pregnancy losses: Th1/Th2/Th9/Th17/Th22/Tfh cells. Front Immunol. 11:20252020. View Article : Google Scholar : PubMed/NCBI

Wu Z, Wang M, Liang G, Jin P, Wang P, Xu Y, Qian Y, Jiang X, Qian J and Dong M: Pro-inflammatory signature in decidua of recurrent pregnancy loss regardless of embryonic chromosomal abnormalities. Front Immunol. 12:7727292021. View Article : Google Scholar : PubMed/NCBI

Vishnyakova P, Elchaninov A, Fatkhudinov T and Sukhikh G: Role of the monocyte-macrophage system in normal pregnancy and preeclampsia. Int J Mol Sci. 20:36952019. View Article : Google Scholar : PubMed/NCBI

Huang SJ, Schatz F, Masch R, Rahman M, Buchwalder L, Niven-Fairchild T, Tang C, Abrahams VM, Krikun G and Lockwood CJ: Regulation of chemokine production in response to pro-inflammatory cytokines in first trimester decidual cells. J Reprod Immunol. 72:60–73. 2006. View Article : Google Scholar : PubMed/NCBI

Gowhari Shabgah A, Jadidi-Niaragh F, Mohammadi H, Ebrahimzadeh F, Oveisee M, Jahanara A and Gholizadeh Navashenaq J: The role of atypical chemokine receptor D6 (ACKR2) in physiological and pathological conditions; friend, foe, or both? Front Immunol. 13:8619312022. View Article : Google Scholar : PubMed/NCBI

Yan S, Cui S, Zhang L, Yang B, Yuan Y, Lv X, Fu H, Li Y, Huang C and Wang P: Expression of ACKR2 in placentas from different types of preeclampsia. Placenta. 90:121–127. 2020. View Article : Google Scholar : PubMed/NCBI

Rybak-Krzyszkowska M, Staniczek J, Kondracka A, Bogusławska J, Kwiatkowski S, Góra T, Strus M and Górczewski W: From biomarkers to the molecular mechanism of preeclampsia-A comprehensive literature review. Int J Mol Sci. 24:132522023. View Article : Google Scholar : PubMed/NCBI

Jena MK, Sharma NR, Petitt M, Maulik D and Nayak NR: Pathogenesis of preeclampsia and therapeutic approaches targeting the placenta. Biomolecules. 10:9532020. View Article : Google Scholar : PubMed/NCBI

Knight JS, Branch DW and Ortel TL: Antiphospholipid syndrome: Advances in diagnosis, pathogenesis, and management. BMJ. 380:e0697172023. View Article : Google Scholar : PubMed/NCBI

Alvarez AM, Mulla MJ, Chamley LW, Cadavid AP and Abrahams VM: Aspirin-triggered lipoxin prevents antiphospholipid antibody effects on human trophoblast migration and endothelial cell interactions. Arthritis Rheumatol. 67:488–497. 2015. View Article : Google Scholar : PubMed/NCBI

Bruno V, Svensson-Arvelund J, Rubér M, Berg G, Piccione E, Jenmalm MC and Ernerudh J: Effects of low molecular weight heparin on the polarization and cytokine profile of macrophages and T helper cells in vitro. Sci Rep. 8:41662018. View Article : Google Scholar : PubMed/NCBI

Saraiva-Mangolin S, Vaz CDO, Ruiz T, Mazetto BM and Orsi FA: Use of hydroxychloroquine to control immune response and hypercoagulability in patients with primary antiphospholipid syndrome. Eur J Intern Med. 90:114–115. 2021. View Article : Google Scholar : PubMed/NCBI

Tishler M, Yaron I, Shirazi I and Yaron M: Hydroxychloroquine treatment for primary Sjögren's syndrome: Its effect on salivary and serum inflammatory markers. Ann Rheum Dis. 58:253–256. 1999. View Article : Google Scholar : PubMed/NCBI

Miranda S, Billoir P, Damian L, Thiebaut PA, Schapman D, Le Besnerais M, Jouen F, Galas L, Levesque H, Le Cam-Duchez V, et al: Hydroxychloroquine reverses the prothrombotic state in a mouse model of antiphospholipid syndrome: Role of reduced inflammation and endothelial dysfunction. PLoS One. 14:e02126142019. View Article : Google Scholar : PubMed/NCBI

Arachchillage DJ, Laffan M and Pericleous C: Hydroxy-chloroquine as an immunomodulatory and antithrombotic treatment in antiphospholipid syndrome. Int J Mol Sci. 24:13312023. View Article : Google Scholar : PubMed/NCBI

Müller-Calleja N, Hollerbach A, Häuser F, Canisius A, Orning C and Lackner KJ: Antiphospholipid antibody-induced cellular responses depend on epitope specificity: Implications for treatment of antiphospholipid syndrome. J Thromb Haemost. 15:2367–2376. 2017. View Article : Google Scholar : PubMed/NCBI

Hollerbach A, Müller-Calleja N, Canisius A, Orning C and Lackner KJ: Induction of tissue factor expression by anti-β2-glycoprotein I is mediated by tumor necrosis factor α. J Thromb Thrombolysis. 49:228–234. 2020. View Article : Google Scholar : PubMed/NCBI

Canaud G, Bienaimé F, Tabarin F, Bataillon G, Seilhean D, Noël LH, Dragon-Durey MA, Snanoudj R, Friedlander G, Halbwachs-Mecarelli L, et al: Inhibition of the mTORC pathway in the antiphospholipid syndrome. N Engl J Med. 371:303–312. 2014. View Article : Google Scholar : PubMed/NCBI

Cornelius DC, Travis OK, Tramel RW, Borges-Rodriguez M, Baik CH, Greer M, Giachelli CA, Tardo GA and Williams JM: NLRP3 inflammasome inhibition attenuates sepsis-induced platelet activation and prevents multi-organ injury in cecal-ligation puncture. PLoS One. 15:e02340392020. View Article : Google Scholar : PubMed/NCBI

Hooftman A, Angiari S, Hester S, Corcoran SE, Runtsch MC, Ling C, Ruzek MC, Slivka PF, McGettrick AF, Banahan K, et al: The immunomodulatory metabolite itaconate modifies NLRP3 and inhibits inflammasome activation. Cell Metab. 32:468–478.e7. 2020. View Article : Google Scholar : PubMed/NCBI

Li Y, Chen X, Zhang H, Xiao J, Yang C, Chen W, Wei Z, Chen X and Liu J: 4-Octyl itaconate alleviates lipopolysaccharide-induced acute lung injury in mice by inhibiting oxidative stress and inflammation. Drug Des Devel Ther. 14:5547–5558. 2020. View Article : Google Scholar : PubMed/NCBI

Tardif JC, Kouz S, Waters DD, Bertrand OF, Diaz R, Maggioni AP, Pinto FJ, Ibrahim R, Gamra H, Kiwan GS, et al: Efficacy and safety of low-dose colchicine after myocardial infarction. N Engl J Med. 381:2497–2505. 2019. View Article : Google Scholar : PubMed/NCBI

Perez-Sanchez C, Ruiz-Limon P, Aguirre MA, Bertolaccini ML, Khamashta MA, Rodriguez-Ariza A, Segui P, Collantes-Estevez E, Barbarroja N, Khraiwesh H, et al: Mitochondrial dysfunction in antiphospholipid syndrome: Implications in the pathogenesis of the disease and effects of coenzyme Q(10) treatment. Blood. 119:5859–5870. 2012. View Article : Google Scholar : PubMed/NCBI

Pérez-Sánchez C, Aguirre MÁ, Ruiz-Limón P, Ábalos-Aguilera MC, Jiménez-Gómez Y, Arias-de la Rosa I, Rodriguez-Ariza A, Fernández-Del Río L, González-Reyes JA, Segui P, et al: Ubiquinol effects on antiphospholipid syndrome prothrombotic profile: A randomized, placebo-controlled trial. Arterioscler Thromb Vasc Biol. 37:1923–1932. 2017. View Article : Google Scholar : PubMed/NCBI

Alijotas-Reig J, Esteve-Valverde E, Llurba E and Gris JM: Treatment of refractory poor aPL-related obstetric outcomes with TNF-alpha blockers: Maternal-fetal outcomes in a series of 18 cases. Semin Arthritis Rheum. 49:314–318. 2019. View Article : Google Scholar : PubMed/NCBI

Sachetto ATA, Archibald SJ, Perkins M, Zhang G, Zhang Y, Ye D, Grover SP, Wu C, Li Z and Mackman N: Pathways regulating the levels of tissue factor-positive extracellular vesicles and activation of coagulation in endotoxemic mice. J Thromb Haemost. 23:2422–2435. 2025. View Article : Google Scholar : PubMed/NCBI

Mantle D and Hargreaves IP: Coenzyme Q10 and autoimmune disorders: An overview. Int J Mol Sci. 25:45762024. View Article : Google Scholar : PubMed/NCBI